Vol 66 No 05: The May Issue

Publication
Article
Contemporary OB/GYN JournalVol 66 No 5
Volume 66
Issue 05

This month’s edition of Contemporary OB/GYN® features three peer-reviewed articles that offer in-depth guidance and analyses of key topics in ob/gyn.

Diagnosis and Management of Primary Dysmenorrhea

Primary dysmenorrhea is a prevalent, underdiagnosed, but treatable condition.

Diagnosis and Management of Gestational Diabetes

What every ob/gyn needs to know to manage this complication.

Enhanced Recovery After Cesarean Section

A case for adopting some Enhanced Recovery After Surgery (ERAS) principles for cesarean delivery.

Read this month's articles as they go live.

Download Issue PDF
Articles in this issue
Methotrexate in an Intrauterine Pregnancy – An Interesting Twist
Methotrexate in an Intrauterine Pregnancy – An Interesting Twist
TTCRF Greatly Improves SUI, Sexual Dysfunction, and Genital Appearance
TTCRF Greatly Improves SUI, Sexual Dysfunction, and Genital Appearance
NASPAG 2021: Hillard’s Highlights
NASPAG 2021: Hillard’s Highlights
Diagnosis and Management of Primary Dysmenorrhea
Diagnosis and Management of Primary Dysmenorrhea
Enhanced Recovery After Cesarean Section
Enhanced Recovery After Cesarean Section
Diagnosis and Management of Gestational Diabetes
Diagnosis and Management of Gestational Diabetes
Keeping Politicians Out of the Exam Room
Keeping Politicians Out of the Exam Room
Behind the Scenes
Behind the Scenes
Vol 66 No 05: The May Issue
Vol 66 No 05: The May Issue
What can you do to reduce maternal severe morbidity and mortality?
What can you do to reduce maternal severe morbidity and mortality?
Prevalence thresholds of screening tests
Prevalence thresholds of screening tests
Hormone therapy for postmenopausal women with nocturia
Hormone therapy for postmenopausal women with nocturia
Pregnancy Hypertensive Disorders Increase Risk of Premature Death
Pregnancy Hypertensive Disorders Increase Risk of Premature Death
Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit: uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
Related Content
Contemporary OB/GYN week in review: Pregnancy prevention, postpartum depression, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Pregnancy prevention, postpartum depression, and more

Celeste Krewson, Assistant Editor
July 26th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

ZY5301 tablet effective for chronic pelvic pain | Image Credit: © valiantsin- stock.adobe.com.

ZY5301 tablet effective for chronic pelvic pain

Celeste Krewson, Assistant Editor
July 25th 2024
Article

These results indicated a significant reduction of CPP from 12 weeks of ZY5301 treatment. Investigators recommended a ZY5301 600 mg/d dose be investigated in a phase 3 trial.

Read More

Site Logo

The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels

September 15th 2023
Podcast

Listen

cUTI Roundtable: The latest therapeutic developments

cUTI Roundtable: The latest therapeutic developments

John Parkinson;Joshua Fitch;Morgan Petronelli, Managing Editor
July 24th 2024
Article

The third and final episode in our series looks at what is in the pipeline as well as a discussion around FDA guidance.

Read More

FDA approves femlyv as the first orally disintegrating tablet for pregnancy prevention | Image Credit: © wladimir1804 - © wladimir1804 - stock.adobe.com.

FDA approves femlyv as the first orally disintegrating tablet for pregnancy prevention

Celeste Krewson, Assistant Editor
July 24th 2024
Article

Femlyv, containing norethindrone acetate and ethinyl estradiol, offers a new oral contraceptive option for individuals with swallowing difficulties, expanding access and convenience.

Read More

© 2024 MJH Life Sciences

All rights reserved.